Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women

Journal of Clinical Virology

Volumn 66, Issue , 2015, Pages 66-71

  Bryant, Dean ^a   Hibbitts, Samantha ^a   Almonte, Maribel ^b   Tristram, Amanda ^a   Fiander, Alison ^a   Powell, Ned ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical; HPV; Human papillomavirus; Methylation; Screening; Young women

Indexed keywords

VIRUS DNA; CAPSID PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; TUMOR MARKER;

ADULT; ARTICLE; COLPOSCOPY; CPG ISLAND; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DYSKARYOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; YOUNG ADULT; COMPLICATION; GENETICS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

BIOMARKERS, TUMOR; CAPSID PROTEINS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84926640154     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.03.001     Document Type: Article

References (29)

1. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
2. Hesselink A.T., Heideman D.A., Steenbergen R.D., Coupe V.M., Overmeer R.M., Rijkaart D., et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin. Cancer Res. 2011, 17:2459-2465.
3. Mirabello L., Sun C., Ghosh A., Rodriguez A.C., Schiffman M., Wentzensen N., et al. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a costa rican population. J. Nat. Cancer Inst. 2012, 104:556-565.
4. Castle P.E. Gynecological cancer: more evidence supporting human papillomavirus testing. Nat. Rev. Clin. Oncol. 2012, 9:131-132.
5. Snijders P.J., Verhoef V.M., Arbyn M., Ogilvie G., Minozzi S., Banzi R., et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int. J. Cancer 2013, 132:2223-2236.
6. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 2012, 137:516-542.
7. Cuzick J., Bergeron C., von Knebel Doeberitz M., Gravitt P., Jeronimo J., Lorincz A.T., et al. New technologies and procedures for cervical cancer screening. Vaccine 2012, 30(Suppl. 5):F107-116.
8. Badal V., Chuang L.S., Tan E.H., Badal S., Villa L.L., Wheeler C.M., et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 2003, 77:6227-6234.
9. Brandsma J.L., Sun Y., Lizardi P.M., Tuck D.P., Zelterman D., Haines G.K., et al. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009, 389:100-107.
10. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 2004, 78:12762-12772.
11. Piyathilake C.J., Macaluso M., Alvarez R.D., Chen M., Badiga S., Edberg J.C., et al. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2011, 117:957-963.
12. Mirabello L., Schiffman M., Ghosh A., Rodriguez A.C., Vasiljevic N., Wentzensen N., et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int. J. Cancer 2013, 132:1412-1422.
13. Bryant D., Tristram A., Liloglou T., Hibbitts S., Fiander A., Powell N. Quantitative measurement of human papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. J. Clin. Virol. 2014, 59:24-29.
14. Hibbitts S., Tristram A., Beer H., McRea J., Rose B., Hauke A., et al. UK population based study to predict impact of HPV vaccination. J. Clin. Virol. 2014, 59:109-114.
15. Hibbitts S., Jones J., Powell N., Dallimore N., McRea J., Beer H., et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br. J. Cancer 2008, 99:1929-1933.
16. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 1997, 35:791-795.
17. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 2001, 29:1165-1188.
18. Lorincz A.T. Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev. Mol. Diagn. 2014, 14:293-305.
19. Bryant D., Onions T., Raybould R., Jones S., Tristram A., Hibbitts S., et al. Increased methylation of human papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia. J. Clin. Virol. 2014.
20. Anon Cancer Statistics Registrations, England (Series MB1), No. 43, 2012. http://wwwonsgovuk/ons/rel/vsob1/cancer-statistics-registrations-england-series-mb1-/no-43-2012/indexhtml.
21. H. Beer, Cervical Screening Wales Statistical Report 2009/2010. (accessed 20.02.15). http://wwwcervicalscreeningwaleswalesnhsuk/sitesplus/documents/1032/KC53-61-65_09-101pdf.
22. Powell N.G., Hibbitts S.J., Boyde A.M., Newcombe R.G., Tristram A.J., Fiander A.N. The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population. Int. J. Cancer 2011, 128:1676-1682.
23. Fernandez A.F., Rosales C., Lopez-Nieva P., Grana O., Ballestar E., Ropero S., et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 2009, 19:438-451.
24. Lorincz A.T., Brentnall A.R., Vasiljevic N., Scibior-Bentkowska D., Castanon A., Fiander A., et al. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int. J. Cancer 2013, 133:637-644.
25. Mirabello L., Frimer M., Harari A., McAndrew T., Smith B., Chen Z., et al. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. Int. J. Cancer 2015, 136:E146-153.
26. Fuchs K., Weitzen S., Wu L., Phipps M.G., Boardman L.A. Management of cervical intraepithelial neoplasia 2 in adolescent and young women. J. Pediatr. Adolesc. Gynecol. 2007, 20:269-274.
27. Moore K., Cofer A., Elliot L., Lanneau G., Walker J., Gold M.A. Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am. J. Obstet. Gynecol. 2007, 197(141):e1-e6.
28. Moscicki A.B., Ma Y., Wibbelsman C., Darragh T.M., Powers A., Farhat S., et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet. Gynecol. 2010, 116:1373-1380.
29. Powell N.G., Smith K., Fiander A. Recovery of human papillomavirus nucleic acids from liquid based cytology media. J. Virol. Methods 2006, 137:58-62.